Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 81

1.

Metabolomic networks connect host-microbiome processes to human Clostridioides difficile infections.

Robinson JI, Weir WH, Crowley JR, Hink T, Reske KA, Kwon JH, Burnham CD, Dubberke ER, Mucha PJ, Henderson JP.

J Clin Invest. 2019 Aug 12;130. pii: 126905. doi: 10.1172/JCI126905. eCollection 2019 Aug 12.

2.

A Culture-Independent Analysis of the Microbiota of Female Interstitial Cystitis/Bladder Pain Syndrome Participants in the MAPP Research Network.

Nickel JC, Stephens-Shields AJ, Landis JR, Mullins C, van Bokhoven A, Lucia MS, Henderson JP, Sen B, Krol JE, Ehrlich GD; MAPP Research Network.

J Clin Med. 2019 Mar 26;8(3). pii: E415. doi: 10.3390/jcm8030415.

3.

The Widely Used Antimicrobial Triclosan Induces High Levels of Antibiotic Tolerance In Vitro and Reduces Antibiotic Efficacy up to 100-Fold In Vivo.

Westfall C, Flores-Mireles AL, Robinson JI, Lynch AJL, Hultgren S, Henderson JP, Levin PA.

Antimicrob Agents Chemother. 2019 Apr 25;63(5). pii: e02312-18. doi: 10.1128/AAC.02312-18. Print 2019 May.

4.

YbtT is a low-specificity type II thioesterase that maintains production of the metallophore yersiniabactin in pathogenic enterobacteria.

Ohlemacher SI, Xu Y, Kober DL, Malik M, Nix JC, Brett TJ, Henderson JP.

J Biol Chem. 2018 Dec 21;293(51):19572-19585. doi: 10.1074/jbc.RA118.005752. Epub 2018 Oct 24.

PMID:
30355735
5.

Clostridium difficile colonization among patients with clinically significant diarrhea and no identifiable cause of diarrhea.

Dubberke ER, Reske KA, Hink T, Kwon JH, Cass C, Bongu J, Burnham CD, Henderson JP.

Infect Control Hosp Epidemiol. 2018 Nov;39(11):1330-1333. doi: 10.1017/ice.2018.225. Epub 2018 Sep 18.

PMID:
30226126
6.

Uropathogenic enterobacteria use the yersiniabactin metallophore system to acquire nickel.

Robinson AE, Lowe JE, Koh EI, Henderson JP.

J Biol Chem. 2018 Sep 28;293(39):14953-14961. doi: 10.1074/jbc.RA118.004483. Epub 2018 Aug 14.

PMID:
30108176
7.

The iron hand of uropathogenic Escherichia coli: the role of transition metal control in virulence.

Robinson AE, Heffernan JR, Henderson JP.

Future Microbiol. 2018 Jun 1;13:745-756. doi: 10.2217/fmb-2017-0295. Epub 2018 Jun 5. Review.

8.

A mass spectrometry based transport assay for studying EmrE transport of unlabeled substrates.

Robinson AE, Henderson JP, Henzler-Wildman KA.

Anal Biochem. 2018 May 15;549:130-135. doi: 10.1016/j.ab.2018.03.017. Epub 2018 Mar 17.

9.

Individualizing Urinary Incontinence Treatment: Research Needs Identified at NIDDK Workshop.

Norton JM, Bradley CS, Brady SS, Brubaker L, Gossett D, Henderson JP, Mazloomdoost D, Musil CM, Rovner E, Bavendam T.

J Urol. 2018 Jun;199(6):1405-1407. doi: 10.1016/j.juro.2017.11.118. Epub 2017 Dec 12. No abstract available.

PMID:
29246733
10.

Enterobacteria secrete an inhibitor of Pseudomonas virulence during clinical bacteriuria.

Ohlemacher SI, Giblin DE, d'Avignon DA, Stapleton AE, Trautner BW, Henderson JP.

J Clin Invest. 2017 Nov 1;127(11):4018-4030. doi: 10.1172/JCI92464. Epub 2017 Sep 25.

11.

Copper import in Escherichia coli by the yersiniabactin metallophore system.

Koh EI, Robinson AE, Bandara N, Rogers BE, Henderson JP.

Nat Chem Biol. 2017 Sep;13(9):1016-1021. doi: 10.1038/nchembio.2441. Epub 2017 Jul 24.

12.

Human Metabolome-derived Cofactors Are Required for the Antibacterial Activity of Siderocalin in Urine.

Shields-Cutler RR, Crowley JR, Miller CD, Stapleton AE, Cui W, Henderson JP.

J Biol Chem. 2016 Dec 9;291(50):25901-25910. Epub 2016 Oct 25.

13.

Urinary Metabolomics Identifies a Molecular Correlate of Interstitial Cystitis/Bladder Pain Syndrome in a Multidisciplinary Approach to the Study of Chronic Pelvic Pain (MAPP) Research Network Cohort.

Parker KS, Crowley JR, Stephens-Shields AJ, van Bokhoven A, Lucia MS, Lai HH, Andriole GL, Hooton TM, Mullins C, Henderson JP.

EBioMedicine. 2016 May;7:167-74. doi: 10.1016/j.ebiom.2016.03.040. Epub 2016 Mar 31.

14.

Network Analysis Reveals Sex- and Antibiotic Resistance-Associated Antivirulence Targets in Clinical Uropathogens.

Parker KS, Wilson JD, Marschall J, Mucha PJ, Henderson JP.

ACS Infect Dis. 2015 Nov 13;1(11):523-532. Epub 2015 Jul 24.

15.

Prevalence of Asymptomatic Bacteriuria in Hospitalized Patients.

Trevino SE, Henderson JP, Wu J, Cass C, Marschall J.

Infect Control Hosp Epidemiol. 2016 Jun;37(6):749-51. doi: 10.1017/ice.2016.56. Epub 2016 Mar 17. No abstract available.

16.

The Yersiniabactin-Associated ATP Binding Cassette Proteins YbtP and YbtQ Enhance Escherichia coli Fitness during High-Titer Cystitis.

Koh EI, Hung CS, Henderson JP.

Infect Immun. 2016 Apr 22;84(5):1312-1319. doi: 10.1128/IAI.01211-15. Print 2016 May.

17.

Perceptions and behaviours of infectious diseases physicians when managing urinary tract infections due to MDR organisms.

Trevino SE, Babcock HM, Henderson JP, Lane MA, Beekmann SE, Polgreen PM, Marschall J.

J Antimicrob Chemother. 2015 Dec;70(12):3397-400. doi: 10.1093/jac/dkv271. Epub 2015 Sep 7.

18.

Deconvoluting heme biosynthesis to target blood-stage malaria parasites.

Sigala PA, Crowley JR, Henderson JP, Goldberg DE.

Elife. 2015 Jul 14;4. doi: 10.7554/eLife.09143.

19.

Low correlation between self-report and medical record documentation of urinary tract infection symptoms.

Echaiz JF, Cass C, Henderson JP, Babcock HM, Marschall J.

Am J Infect Control. 2015 Sep 1;43(9):983-6. doi: 10.1016/j.ajic.2015.04.208. Epub 2015 Jun 16.

20.

Microbial Copper-binding Siderophores at the Host-Pathogen Interface.

Koh EI, Henderson JP.

J Biol Chem. 2015 Jul 31;290(31):18967-74. doi: 10.1074/jbc.R115.644328. Epub 2015 Jun 8. Review.

21.

Human Urinary Composition Controls Antibacterial Activity of Siderocalin.

Shields-Cutler RR, Crowley JR, Hung CS, Stapleton AE, Aldrich CC, Marschall J, Henderson JP.

J Biol Chem. 2015 Jun 26;290(26):15949-60. doi: 10.1074/jbc.M115.645812. Epub 2015 Apr 10.

22.

Metal selectivity by the virulence-associated yersiniabactin metallophore system.

Koh EI, Hung CS, Parker KS, Crowley JR, Giblin DE, Henderson JP.

Metallomics. 2015 Jun;7(6):1011-22. doi: 10.1039/c4mt00341a.

23.

The heme biosynthesis pathway is essential for Plasmodium falciparum development in mosquito stage but not in blood stages.

Ke H, Sigala PA, Miura K, Morrisey JM, Mather MW, Crowley JR, Henderson JP, Goldberg DE, Long CA, Vaidya AB.

J Biol Chem. 2014 Dec 12;289(50):34827-37. doi: 10.1074/jbc.M114.615831. Epub 2014 Oct 28.

24.

Pathogenic adaptations to host-derived antibacterial copper.

Chaturvedi KS, Henderson JP.

Front Cell Infect Microbiol. 2014 Feb 3;4:3. doi: 10.3389/fcimb.2014.00003. eCollection 2014. Review.

25.

Metabolomic analysis of siderophore cheater mutants reveals metabolic costs of expression in uropathogenic Escherichia coli.

Lv H, Hung CS, Henderson JP.

J Proteome Res. 2014 Mar 7;13(3):1397-404. doi: 10.1021/pr4009749. Epub 2014 Feb 7.

26.

The bacterial amyloid curli is associated with urinary source bloodstream infection.

Hung C, Marschall J, Burnham CA, Byun AS, Henderson JP.

PLoS One. 2014 Jan 20;9(1):e86009. doi: 10.1371/journal.pone.0086009. eCollection 2014.

27.

Cupric yersiniabactin is a virulence-associated superoxide dismutase mimic.

Chaturvedi KS, Hung CS, Giblin DE, Urushidani S, Austin AM, Dinauer MC, Henderson JP.

ACS Chem Biol. 2014 Feb 21;9(2):551-61. doi: 10.1021/cb400658k. Epub 2013 Dec 11.

28.

Weekend diagnosis of Escherichia coli urinary tract infection does not predict poor outcome.

Echaiz JF, Henderson JP, Warren DK, Marschall J.

Epidemiol Infect. 2014 Jul;142(7):1422-4. doi: 10.1017/S095026881300229X. Epub 2013 Sep 23.

29.

Escherichia coli biofilms have an organized and complex extracellular matrix structure.

Hung C, Zhou Y, Pinkner JS, Dodson KW, Crowley JR, Heuser J, Chapman MR, Hadjifrangiskou M, Henderson JP, Hultgren SJ.

MBio. 2013 Sep 10;4(5):e00645-13. doi: 10.1128/mBio.00645-13.

30.

Vancomycin resistance has no influence on outcomes of enterococcal bacteriuria.

Khair HN, VanTassell P, Henderson JP, Warren DK, Marschall J; CDC Prevention Epicenters Program.

J Hosp Infect. 2013 Nov;85(3):183-8. doi: 10.1016/j.jhin.2013.07.007. Epub 2013 Aug 30.

31.

Patient characteristics but not virulence factors discriminate between asymptomatic and symptomatic E. coli bacteriuria in the hospital.

Marschall J, Piccirillo ML, Foxman B, Zhang L, Warren DK, Henderson JP; CDC Prevention Epicenters Program.

BMC Infect Dis. 2013 May 10;13:213. doi: 10.1186/1471-2334-13-213.

32.

Genomic diversity and fitness of E. coli strains recovered from the intestinal and urinary tracts of women with recurrent urinary tract infection.

Chen SL, Wu M, Henderson JP, Hooton TM, Hibbing ME, Hultgren SJ, Gordon JI.

Sci Transl Med. 2013 May 8;5(184):184ra60. doi: 10.1126/scitranslmed.3005497.

33.

Direct tests of enzymatic heme degradation by the malaria parasite Plasmodium falciparum.

Sigala PA, Crowley JR, Hsieh S, Henderson JP, Goldberg DE.

J Biol Chem. 2012 Nov 2;287(45):37793-807. doi: 10.1074/jbc.M112.414078. Epub 2012 Sep 19.

34.

The siderophore yersiniabactin binds copper to protect pathogens during infection.

Chaturvedi KS, Hung CS, Crowley JR, Stapleton AE, Henderson JP.

Nat Chem Biol. 2012 Aug;8(8):731-6. doi: 10.1038/nchembio.1020. Epub 2012 Jul 8.

35.

Combinatorial small-molecule therapy prevents uropathogenic Escherichia coli catheter-associated urinary tract infections in mice.

Guiton PS, Cusumano CK, Kline KA, Dodson KW, Han Z, Janetka JW, Henderson JP, Caparon MG, Hultgren SJ.

Antimicrob Agents Chemother. 2012 Sep;56(9):4738-45. doi: 10.1128/AAC.00447-12. Epub 2012 Jun 25.

36.

Structural engineering of a phage lysin that targets gram-negative pathogens.

Lukacik P, Barnard TJ, Keller PW, Chaturvedi KS, Seddiki N, Fairman JW, Noinaj N, Kirby TL, Henderson JP, Steven AC, Hinnebusch BJ, Buchanan SK.

Proc Natl Acad Sci U S A. 2012 Jun 19;109(25):9857-62. doi: 10.1073/pnas.1203472109. Epub 2012 Jun 7.

37.

Lead optimization studies on FimH antagonists: discovery of potent and orally bioavailable ortho-substituted biphenyl mannosides.

Han Z, Pinkner JS, Ford B, Chorell E, Crowley JM, Cusumano CK, Campbell S, Henderson JP, Hultgren SJ, Janetka JW.

J Med Chem. 2012 Apr 26;55(8):3945-59. doi: 10.1021/jm300165m. Epub 2012 Apr 13.

38.

Both host and pathogen factors predispose to Escherichia coli urinary-source bacteremia in hospitalized patients.

Marschall J, Zhang L, Foxman B, Warren DK, Henderson JP; CDC Prevention Epicenters Program.

Clin Infect Dis. 2012 Jun;54(12):1692-8. doi: 10.1093/cid/cis252. Epub 2012 Mar 19.

39.

Treatment and prevention of urinary tract infection with orally active FimH inhibitors.

Cusumano CK, Pinkner JS, Han Z, Greene SE, Ford BA, Crowley JR, Henderson JP, Janetka JW, Hultgren SJ.

Sci Transl Med. 2011 Nov 16;3(109):109ra115. doi: 10.1126/scitranslmed.3003021.

40.

Yersinia high pathogenicity island genes modify the Escherichia coli primary metabolome independently of siderophore production.

Lv H, Henderson JP.

J Proteome Res. 2011 Dec 2;10(12):5547-54. doi: 10.1021/pr200756n. Epub 2011 Nov 15.

41.

Not all nosocomial Escherichia coli bacteriurias are catheter associated.

Marschall J, Ota KN, Henderson JP, Warren DK.

Infect Control Hosp Epidemiol. 2011 Nov;32(11):1140-2. doi: 10.1086/662587. Epub 2011 Oct 6. No abstract available.

42.

Advancing recertification for nurse anesthetists in an environment of increased accountability.

Plaus K, Muckle TJ, Henderson JP.

AANA J. 2011 Oct;79(5):413-8.

PMID:
23256271
43.

Development of an integrated metabolomic profiling approach for infectious diseases research.

Lv H, Hung CS, Chaturvedi KS, Hooton TM, Henderson JP.

Analyst. 2011 Nov 21;136(22):4752-63. doi: 10.1039/c1an15590c. Epub 2011 Sep 16.

44.

A central metabolic circuit controlled by QseC in pathogenic Escherichia coli.

Hadjifrangiskou M, Kostakioti M, Chen SL, Henderson JP, Greene SE, Hultgren SJ.

Mol Microbiol. 2011 Jun;80(6):1516-29. doi: 10.1111/j.1365-2958.2011.07660.x. Epub 2011 May 5.

45.

Emerging concepts of biofilms in infectious diseases.

Hung CS, Henderson JP.

Mo Med. 2009 Jul-Aug;106(4):292-6.

PMID:
19753923
46.

Cauda equina syndrome (CES) from lumbar disc herniations.

Olivero WC, Wang H, Hanigan WC, Henderson JP, Tracy PT, Elwood PW, Lister JR, Lyle L.

J Spinal Disord Tech. 2009 May;22(3):202-6. doi: 10.1097/BSD.0b013e31817baad8.

PMID:
19412023
47.

Quantitative metabolomics reveals an epigenetic blueprint for iron acquisition in uropathogenic Escherichia coli.

Henderson JP, Crowley JR, Pinkner JS, Walker JN, Tsukayama P, Stamm WE, Hooton TM, Hultgren SJ.

PLoS Pathog. 2009 Feb;5(2):e1000305. doi: 10.1371/journal.ppat.1000305. Epub 2009 Feb 20.

48.

An assessment of the effectiveness of the Mosquito Magnet Pro Model for suppression of nuisance mosquitoes.

Henderson JP, Westwood R, Galloway T.

J Am Mosq Control Assoc. 2006 Sep;22(3):401-7.

PMID:
17067037
49.

Suicide - a statistical analysis by age, sex and method.

Henderson JP, Mellin C, Patel F.

J Clin Forensic Med. 2005 Dec;12(6):305-9. Epub 2005 Sep 26.

PMID:
16188480
50.

Mercury in an assortment of processed and unprocessed seafood samples.

Levine KE, Levine MA, Weber FX, Henderson JP, Grohse PM.

Bull Environ Contam Toxicol. 2005 May;74(5):973-9. No abstract available.

PMID:
16097334

Supplemental Content

Loading ...
Support Center